We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Unreported MDRs, Corrective Actions Lead to Form 483 for B. Braun
Unreported MDRs, Corrective Actions Lead to Form 483 for B. Braun
January 3, 2013
Multiple failures to report adverse events and corrective actions to the FDA were cited in a six-observation Form 483 issued to B. Braun Medical at the conclusion of a June 25 to Aug. 16 inspection of its Carrollton, Texas, facility.